Get the Stockscreener App
18.81
8.48%
1.47
Upstream Bio Inc stock is traded at $18.81, with a volume of 783.03K.
It is up +8.48% in the last 24 hours and up +9.81% over the past month.
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
See More
Previous Close:
$17.34
Open:
$17.34
24h Volume:
783.03K
Relative Volume:
1.51
Market Cap:
$1.01B
Revenue:
$2.22M
Net Income/Loss:
$-40.51M
P/E Ratio:
-14.64
EPS:
-1.2847
Net Cash Flow:
$-46.53M
1W Performance:
+15.54%
1M Performance:
+9.81%
6M Performance:
+207.35%
1Y Performance:
+0.00%
1-Day Range:
$17.14
$19.23
1-Week Range:
$16.02
$19.23
52-Week Range:
$5.14
$29.46
Upstream Bio Inc Stock (UPB) Company Profile
Name
Upstream Bio Inc
Sector
Industry
Phone
781-208-2466
Address
890 WINTER STREET, SUITE 200, WALTHAM
Compare UPB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
18.81 | 934.79M | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | Piper Sandler | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
Upstream Bio Inc Stock (UPB) Latest News
Is Upstream Bio Inc. stock attractive for passive investorsCPI Data & AI Powered Buy and Sell Recommendations - newser.com
Is Upstream Bio Inc. building a consolidation base2025 Short Interest & Fast Moving Trade Plans - newser.com
Earnings visualization tools for Upstream Bio Inc.2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Upstream Bio Presents Data Showing Structural and - GlobeNewswire
24-Week TSLP Inhibition: Upstream Bio's Verekitug Shows Breakthrough Respiratory Disease Treatment Data - Stock Titan
Visualizing Upstream Bio Inc. stock with heatmapsStock Surge & Expert Curated Trade Setups - newser.com
News impact scoring models applied to Upstream Bio Inc.Fed Meeting & Weekly High Potential Stock Alerts - newser.com
Applying Elliott Wave Theory to Upstream Bio Inc.Short Setup & Daily Risk Controlled Trade Plans - newser.com
Why retail investors pile into Upstream Bio Inc. stockJuly 2025 Snapshot & Smart Allocation Stock Tips - newser.com
Can volume confirm reversal in Upstream Bio Inc.2025 Retail Activity & Real-Time Stock Entry Alerts - newser.com
Upstream Bio, Inc. $UPB Shares Sold by Goldman Sachs Group Inc. - Defense World
What drives Upstream Bio Inc stock pricePrice Action Trading & Affordable Market Growth - earlytimes.in
Is Upstream Bio Inc. forming a reversal patternEarnings Recap Report & AI Forecast Swing Trade Picks - newser.com
How sentiment analysis helps forecast Upstream Bio Inc.2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com
Is a relief rally coming for Upstream Bio Inc. holdersJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com
Upstream Bio (NASDAQ:UPB) Stock Price Down 5.3%Here's Why - MarketBeat
Upstream Bio Inc.’s volatility index tracking explainedJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Upstream Bio, Inc.(NasdaqGS: UPB) added to S&P Biotechnology Select Industry Index - MarketScreener
Upstream Bio (NASDAQ:UPB) Trading Up 5.9%What's Next? - MarketBeat
Upstream Bio Inc Stock (UPB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):